Tag: SAFE

Den 12. maj 2026 igangsatte Gabriel Holding A/S et aktietilbagekøbsprogram. Aktietilbagekøbet løber i perioden fra og med den 12. maj til og med den 16. marts 2027. I denne periode kan Gabriel Holding A/S tilbagekøbe op til en samlet beholdning på 94.500 egne aktier svarende til 5 % af aktiekapitalen.

The new storefront expands the company's safe and vault openings, commercial door and frame replacement, access control, and automotive key services from Montrose into the greater Grand Junction and Mesa County market.

The new storefront expands the company's safe and vault openings, commercial door and frame replacement, access control, and automotive key services from Montrose into the greater Grand Junction and Mesa County market.

NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,409 restricted stock units of the company’s common stock to 15 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of June 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).

TORONTO, June 19, 2026 /CNW/ - Members of the Registered Nurses' Association of Ontario (RNAO) and its Rainbow Nursing Interest Group (RNIG) are expanding...

Social Media #moveover Campaign Reinforces Scott's LawBELLEVILLE, Ill., June 19, 2026 /PRNewswire/ -- As the National Safety Council's National Safety Month ends, Illinois American...

GREENVILLE, N.C., June 19, 2026 /PRNewswire/ -- Is it safe to start remodeling an older home in Greenville, NC if it looks solid at...

Former Sterling McCall Lexus location is among the dealerships now operating under the unified Group 1 brandHOUSTON, June 19, 2026 /PRNewswire/ -- As part...

FLORHAM PARK, N.J., June 19, 2026 (GLOBE NEWSWIRE) -- Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved an update to the labeled strength of TWIRLA® (levonorgestrel and ethinyl estradiol) transdermal system. The new labeled strength will begin to appear on the market in September or October of 2026.

The Nation's 250th Birthday Means Expanded Celebrations and More Boaters on the Waterways ORLANDO, Fla., June 19, 2026 /PRNewswire/ -- Waterfront venues across the United States...

CHICAGO, June 19, 2026 /PRNewswire/ -- GO Airport Shuttle (GOWithUs.com) announced that John McCarthy, President, The GO Group, its parent company, was awarded the...

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

HAIKOU, China, June 19, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn: Six months after the launch of island-wide special customs operations, the Hainan Free Trade...

Imara Sickle Cell Framework aims to help countries turn policy priorities into coordinated diagnosis, treatment and lifelong careNAIROBI, Kenya and KAMPALA, Uganda, June 19,...

SpaceBev X, brings its boldest flavor yet to Walmart.com and Trumpdriveenergy.com on July 4, 2026BOCA RATON, Fla., June 19, 2026 /PRNewswire/ -- Trumpdrive Energy®,...